Peter Moriarty

Scottsdale, AZ (USA)
Role(s):
Founder/Owner/Principal

Prismic Pharmaceuticals, Inc.

Location: Scottsdale
Industry: Healthcare
Year Founded: 2011
Number Employees: 1-10 people
Business Stage: Growth (not profitable)
Entity Type: "C" Corporation
Description: ¬ Prismic, founded by pharmaceutical industry veterans with a history of success, focuses on the development of patent protected products derived from natural sources with unique safety profiles to address inflammation and oxidative stress inflammation, considered to be underlying causes of many of the most commonly occurring disorders associated with the “baby boomer” population. This includes Diabetes, and its frequently concomitant serious complications such as Chronic Kidney Disease and also Depression, which are Prismic’s two key areas of focus. Rather than spending a decade or longer and hundreds of millions of dollars developing traditional prescription drugs, Prismic is focused on the development of prescription Medical Foods Under this FDA category (Orphan Drug Act), safe and effective products can be rapidly brought to market at a fraction of the cost of traditional prescription drugs, namely, – 24 – 36 months – from inception to launch – At a cost of $2.5 million – $4.0 million per product This provides Prismic and its investors with: – Low-cost – Low-risk – Fast-to-market opportunities